RAC 4 Aug 2025, 1:57 PM

Phase 2 Bisantrene AML Trial Results Published

Racura Oncology Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in